Injective Protocol's $INJ Gains Momentum on Top 10 Revenue and High Code Commits as Price Targets $30

Injective Protocol’s native token, $INJ, has drawn renewed market attention as the blockchain platform advances toward a critical price target of $30. Recent developments highlight Injective’s growing influence in the decentralized finance (DeFi) space, with the network now ranking among the top 10 blockchains by protocol revenue and achieving the highest volume of code commits among Layer 1 (L1) networks. These metrics underscore a combination of financial sustainability and active technical development, positioning Injective as a formidable contender in the evolving blockchain landscape [1].

The surge in protocol revenue places Injective in an elite category of blockchain projects. Ranking within the top 10 by revenue signifies that the platform is not only attracting users but also generating substantial value through transaction fees, staking rewards, and other revenue streams. This financial traction validates the network’s utility and ecosystem growth, as projects with robust revenue models are often seen as more resilient in volatile markets [1]. Concurrently, Injective’s leadership in code commits—a measure of developer activity—highlights the project’s commitment to iterative improvements and infrastructure resilience. High code commit rates are typically associated with active, community-driven development, suggesting that the Injective network is continuously adapting to meet user demands and technological challenges [1].

Market participants are increasingly aligning with these fundamentals. The $INJ token has shown a clear trajectory toward the $30 level, driven by institutional interest and expanding adoption of Injective’s DeFi tools. Analysts note that the convergence of on-chain performance and price action creates a compelling narrative for further appreciation. “The alignment of revenue growth, developer activity, and market sentiment forms a solid foundation for $INJ’s move toward $30,” according to recent commentary [1]. This optimism is echoed by Crypto Rand, a prominent figure in the crypto space, who highlighted Injective’s dual achievements in a July 28, 2025, tweet, emphasizing the project’s momentum [1].

The platform’s ecosystem expansion further reinforces its potential. New protocols and integrations are being introduced at a rapid pace, attracting both retail and institutional users. This growth is supported by Injective’s interoperability features, which allow seamless interaction with other blockchain networks. As the platform continues to onboard developers and users, its ability to maintain high code commit rates and revenue generation will be critical in sustaining long-term value [1].

Injective’s journey toward $30 is not without risks, as volatility remains inherent to the crypto market. However, the project’s current trajectory suggests that its technical and financial metrics are well-positioned to support a significant price milestone. With continued innovation and expanding utility, Injective may yet solidify its place among the leading L1 networks.

Source: [1] [Injective Blockchain Surges Toward $30 Milestone] [https://coinmarketcap.com/community/articles/68876ae42477c254f74c0e20/]